ConductScience.org, home

Paper17530850

Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.

Kim D and 4 others. J Am Chem Soc, 2007. Cited by 529 papers, by iCite.

Cite this record

ConductScience Library. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. Papers, record 17530850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17530850

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
PubMed
Journal
J Am Chem Soc
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
529
iCite
Relative citation ratio, by iCite
14.6
iCite
Revised in PubMed
2023-11-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim DDongkyu
2Park SSangjin
3Lee JHJae Hyuk
4Jeong YYYong Yeon
5Jon SSangyong

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contrast MediaMajor topic
GoldMajor topic
Metal NanoparticlesMajor topic
PolymersMajor topic
Animals
Carcinoma, Hepatocellular
Male
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Cited by187

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 529 citations.

PMIDTitleJournalYearIn PapersSource
42909384Atherosclerosis nanotheranostics: a perspective from macrophages.Theranostics2026https://conductscience.org/library/papers/42909384PubMed
42376707Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.Chembiochem2026https://conductscience.org/library/papers/42376707PubMed
41940236Metallic nanoparticles: from biosynthesis to biomedical applications, current scenarios and prospects.Nanoscale Adv2026https://conductscience.org/library/papers/41940236PubMed
40661692Metallic Nanoparticles Applications in Neurological Disorders: A Review.Int J Biomater2025https://conductscience.org/library/papers/40661692PubMed
39989765Advancements in Micro/Nanorobots in Medicine: Design, Actuation, and Transformative Application.ACS Omega2025https://conductscience.org/library/papers/39989765PubMed
39046153Charged Gold Nanoparticles for Target Identification-Alignment and Automatic Segmentation of CT Image-Guided Adaptive Radiotherapy in Small Hepatocellular Carcinoma.Nano Lett2024https://conductscience.org/library/papers/39046153PubMed
38332327Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance.Sci Prog2024https://conductscience.org/library/papers/38332327PubMed
38164503Gold Polymer Nanomaterials: A Promising Approach for Enhanced Biomolecular Imaging.Nanotheranostics2024https://conductscience.org/library/papers/38164503PubMed
38089921Progress and prospect of nanotechnology for cardiac fibrosis treatment.Interdiscip Med2023https://conductscience.org/library/papers/38089921PubMed
37895934Heavy Metal-Based Nanoparticles as High-Performance X-ray Computed Tomography Contrast Agents.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37895934PubMed
37876497Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors.ACS Bio Med Chem Au2023https://conductscience.org/library/papers/37876497PubMed
37842655Applications and safety of gold nanoparticles as therapeutic devices in clinical trials.J Pharm Anal2023https://conductscience.org/library/papers/37842655PubMed
36903686Facile Synthesis and X-ray Attenuation Properties of Ultrasmall Platinum Nanoparticles Grafted with Three Types of Hydrophilic Polymers.Nanomaterials (Basel)2023https://conductscience.org/library/papers/36903686PubMed
36866254Green room temperature synthesis of silver-gold alloy nanoparticles.Nanoscale Adv2023https://conductscience.org/library/papers/36866254PubMed
36865684Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts.Cancer Nanotechnol2023https://conductscience.org/library/papers/36865684PubMed
36741760Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/36741760PubMed
36687113Chemically Functionalized Gold Nanosphere-Blended Nematic Liquid Crystals for Photonic Applications.ACS Omega2023https://conductscience.org/library/papers/36687113PubMed
36662059Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics.J Funct Biomater2022https://conductscience.org/library/papers/36662059PubMed
36318182Zonal Intratumoral Delivery of Nanoparticles Guided by Surface Functionalization.Langmuir2022https://conductscience.org/library/papers/36318182PubMed
36313319Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications.Front Pharmacol2022https://conductscience.org/library/papers/36313319PubMed

See all 187 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17530850

GET https://conductscience.org/api/papers/v1/17530850/cited_by?page=2